Jeevan Scientific Technology News

Jeevan Scientific Gets US FDA Assessment Report

Jeevan Scientific Technology Limited receives US FDA Remote Regulatory Assessment Report following review of its Hyderabad clinical pharmacology facility from October-November 2025.

Jeevan Scientific Promoters Acquire 30L Warrants

Multiple promoters of Jeevan Scientific Technology acquired 30,00,000 convertible warrants through preferential allotment on January 2, with Krishna Kishore Kuchipudi leading with 12,00,000 warrants.

Jeevan Scientific Acquires Naya Pharma for ₹10 Cr

Jeevan Scientific Technology announces acquisition of 60% stake in Naya Pharma Private Limited for ₹10 crores, funded through preferential issue proceeds approved in November 2025.

Jeevan Scientific Technology Limited Shareholders Approve All Four Resolutions in Extraordinary General Meeting

Jeevan Scientific Technology Limited held an Extraordinary General Meeting on November 12, 2025, through video conferencing from 10:00 AM to 10:40 AM. The meeting had 58 members in attendance out of 5,436 total shareholders on record date. All four proposed resolutions were passed with requisite majority: adoption of Memorandum of Association as per Companies Act 2013, increase in authorized share capital and consequent alteration of capital clause, issue of convertible warrants on preferential basis to promoters and non-promoters for cash consideration, and issue of equity shares on preferential basis to non-promoters for cash consideration. The voting was conducted through remote e-voting (November 9-11, 2025) and electronic voting during the meeting. AakankshaSachin Dubey served as the scrutinizer for the voting process.